Potassium binding polymers for treating hypertension and hyperkalemia

作者: Gerrit Klaerner , Lance Berman

DOI:

关键词:

摘要: The present invention generally relates to methods of treating hypertension (HTN) in patients need thereof wherein the patient optionally further suffers from chronic kidney disease (CKD) or Type II diabetes mellitus (T2DM). also hyperkalemia a thereof, CKD, T2DM HTN and are being treated with an effective amount renin-angiotensin-aldosterone system (RAAS) agent. is can comprise administering potassium-binding polymer lower patient's blood pressure and/or increase stabilize function.

参考文章(122)
Barbara Roniker, John C. Alexander, Richard J. LaChapelle, Alfonzo T. Perez, Debra J. Asner, Methods of treating heart failure and hypertension using combinations of eplerenone and an angiotensin converting enzyme inhibitor ,(2002)
Annette Notenbomer, Particles for binding monovalent cations ,(1993)
Stephen Randall Holmes-Farley, W. Harry Mandeville, Process for adjusting ion concentration in a patient and compositions therefor ,(1994)
Quentin Jean-Pierre, Gardon Roger, Microcapsules for use in artificial kidney machines ,(1973)
I-Wen Wu, Chin-Chan Lee, Mai-Szu Wu, Shun-Yin Wang, Ming-Fang Hsieh, Higher serum potassium level associated with late stage chronic kidney disease Chang Gung medical journal. ,vol. 34, pp. 418- 425 ,(2011)